GlassScriptPhysician profile
Amanda N Berry
NPI 1104359728
$4,972.23
in general payments reported to CMS, 2019-2025
21 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $75.61 · 2022: $860 · 2023: $3,261 · 2024: $371 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,565 · Food and Beverage: $1,193 · Travel and Lodging: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,564.95 |
| Food and Beverage | $1,193.24 |
| Travel and Lodging | $1,178.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,497.02 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $328.08 | 2022-2025 | Thinprep 2000 Processor, Acessa Provu System, Aptima |
| Organon LLC | $246.60 | 2022-2025 | Nexplanon, Nuvaring |
| Coopersurgical, INC. | $125.48 | 2020-2025 | Paragard T 380a |
| Astellas Pharma US INC | $104.85 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $101.30 | 2021-2022 | |
| Conmed Corporation | $83.33 | 2023 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $75.90 | 2023-2024 | |
| Abbvie INC. | $71.09 | 2021-2022 | |
| Exeltis, USA INC. | $63.13 | 2022-2025 | Slynd, Tyblume |
| Sumitomo Pharma America, INC. | $49.21 | 2025 | Myfembree |
| Minerva Surgical, INC | $36.96 | 2023 | |
| Boston Scientific Corporation | $34.44 | 2022 | |
| Mayne Pharma Commercial LLC | $34.19 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.31 | 2023 | Ultomiris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.08 | 2025 | Gardasil 9 |
| Pfizer INC. | $17.07 | 2024 | |
| Lilly USA, LLC | $16.84 | 2024 | Zepbound |
| Becton, Dickinson and Company | $16.57 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $16.21 | 2023 | Vivjoa |
| Medtronic, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.